Cumberland Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US2307701092

SecurityCPIX / Cumberland Pharmaceuticals Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership411,786 shares
Latest Disclosed Value $ 1,638,909
Vanguard Group Inc ownership in CPIX / Cumberland Pharmaceuticals Inc.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 411,786 shares of Cumberland Pharmaceuticals Inc. (US:CPIX) valued at $1,638,908 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 411,786 shares of Cumberland Pharmaceuticals Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,310,119 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 411,786 0 0.00 1,639 27.57 0.0000
2025-11-07 2025-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 411,786 0 0.00 1,285 -6.89 0.0000
2025-08-11 2025-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 411,786 -4,783 -1.15 1,379 -21.74 0.0000
2025-05-09 2025-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 416,569 42,318 11.31 1,762 98.87 0.0000
2025-02-11 2024-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,251 0 0.00 887 84.97 0.0000
2024-11-13 2024-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,251 0 0.00 479 -16.26 0.0000
2024-08-13 2024-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,251 0 0.00 573 -8.92 0.0000
2024-05-10 2024-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,251 0 0.00 629 -6.27 0.0000
2024-03-11 2023-12-31 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 374,251 1,125 0.30 671 -4.96 0.0000
2024-02-14 2023-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,251 1,125 671 0.0000
2023-12-18 2023-09-30 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 373,126 -1,700 -0.45 705 28.18 0.0000
2023-11-14 2023-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 373,126 -1,700 705 0.0000
2023-08-14 2023-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,826 0 0.00 551 -24.66 0.0000
2023-07-14 2023-03-31 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 374,826 0 0.00 731 -13.40 0.0000
2023-05-15 2023-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,826 0 731 0.0000
2023-02-10 2022-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,826 135 0.04 843 -6.64 0.0000
2022-11-14 2022-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,691 0 0.00 903 16.07 0.0000
2022-08-12 2022-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 374,691 -3,293 -0.87 778 -27.02 0.0000
2022-05-13 2022-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 377,984 -13,195 -3.37 1,066 -41.62 0.0000
2022-02-14 2021-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,179 -417 -0.11 1,826 73.90 0.0000
2021-11-12 2021-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,596 0 0.00 1,050 -5.83 0.0000
2021-08-13 2021-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,596 0 0.00 1,115 -5.99 0.0000
2021-05-14 2021-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,596 0 0.00 1,186 2.68 0.0000
2021-02-12 2020-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,596 -99 -0.03 1,155 -8.11 0.0000
2020-11-16 2020-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,695 0 0.00 1,257 -3.68 0.0000
2020-08-14 2020-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,695 0 0.00 1,305 -8.23 0.0000
2020-05-15 2020-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,695 0 0.00 1,422 -29.53 0.0001
2020-02-14 2019-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,695 99 0.03 2,018 -13.09 0.0001
2019-11-14 2019-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 391,596 22,871 6.20 2,322 -1.15 0.0001
2019-08-14 2019-06-30 13F CUMBERLAND PHARMACEUTICALS COM 230770109 368,725 0 0.00 2,349 9.66 0.0001
2019-05-15 2019-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 368,725 54,701 17.42 2,142 8.24 0.0001
2019-02-14 2018-12-31 13F CUMBERLAND PHARMACEUTICALS COM 230770109 314,024 260 0.08 1,979 10.50 0.0001
2018-12-13 2018-09-30 13F/A-2 CUMBERLAND PHARMACEUTICALS I COM 230770109 313,764 0 0.00 1,791 -6.86 0.0001
2018-11-23 2018-09-30 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 313,764 0 1,791 0.0001
2018-11-14 2018-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 313,764 0 1,791
2018-08-14 2018-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 313,764 0 0.00 1,923 -8.25 0.0001
2018-05-15 2018-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 313,764 -2,473 -0.78 2,096 -10.69 0.0001
2018-02-14 2017-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 316,237 13,287 4.39 2,347 9.72 0.0001
2017-11-14 2017-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 302,950 4,315 1.44 2,139 1.33 0.0001
2017-08-24 2017-06-30 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 298,635 1,180 0.40 2,111 2.28 0.0001
2017-08-11 2017-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 298,635 1,180 2,111
2017-05-12 2017-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 297,455 0 0.00 2,064 26.16 0.0001
2017-02-14 2016-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 297,455 -668 -0.22 1,636 9.58 0.0001
2016-11-14 2016-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 298,123 900 0.30 1,493 11.67 0.0001
2016-08-10 2016-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 297,223 2,600 0.88 1,337 1.06 0.0001
2016-05-13 2016-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 294,623 5,003 1.73 1,323 -13.13 0.0001
2016-02-08 2015-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 289,620 5,500 1.94 1,523 -7.08 0.0001
2015-11-12 2015-09-30 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 284,120 0 0.00 1,639 -19.30 0.0001
2015-11-12 2015-09-30 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 284,120 0 1,639 0.0001
2015-11-12 2015-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 4,704,462 158,150
2015-08-13 2015-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 284,120 -1,426 -0.50 2,031 6.78 0.0001
2015-05-15 2015-03-31 13F/A-1 CUMBERLAND PHARMACEUTICALS I COM 230770109 285,546 6,114 2.19 1,902 13.42 0.0001
2015-05-14 2015-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 285,546 1,902
2015-02-12 2014-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 279,432 7,700 2.83 1,677 24.96 0.0001
2014-11-12 2014-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 271,732 0 0.00 1,342 9.73 0.0001
2014-08-11 2014-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 271,732 2,900 1.08 1,223 1.16 0.0001
2014-05-13 2014-03-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 268,832 1,000 0.37 1,209 -11.69 0.0001
2014-02-12 2013-12-31 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 267,832 0 0.00 1,369 12.86 0.0001
2013-11-07 2013-09-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 267,832 0 0.00 1,213 -11.40 0.0001
2013-08-13 2013-06-30 13F CUMBERLAND PHARMACEUTICALS I COM 230770109 267,832 267,832 1,369 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.